Basic Information
Basic information for MIR646HG-217-34aa
Peptide Name MIR646HG-217-34aa
Genome Position chr20:60126346-60126447[+]
Species Human
Peptide Sequence MLISKEPSQKHHHASSQRRNAHLHPNRKGPGIHL
Peptide Length 34
Unique No (MIR646HG-213-34aa-2,MIR646HG-215-34aa,MIR646HG-222-34aa,MIR646HG-229-34aa,MIR646HG-234-34aa,MIR646HG-246-34aa,MIR646HG-253-34aa-1,MIR646HG-254-34aa)
Grand Average of Hydropathicity -1.3176
Relative Molecular Mass 4494.93
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000654038;MIR646HG-217
Transcript Length 1422
Coding Ability 0.3319
DNA Sequence Corresponding to Peptide ATGTTAATTTCCAAAGAGCCATCACAGAAACATCATCATGCTTCCTCACAAAGAAGAAATGCTCACCTCCACCCCAATAGAAAGGGTCCAGGTATCCATCTC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :